Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris.

Source:http://linkedlifedata.com/resource/pubmed/id/18602514

Am. J. Cardiol. 2008 Jul 15 102 2 160-4

Download in:

View as

General Info

PMID
18602514